Plasma exchange (PE)
Sponsors
Peking University First Hospital, Xuanwu Hospital, Beijing, Sanofi, Shanghai Bao Pharmaceuticals Co., Ltd., Tianjin Medical University General Hospital
Conditions
Acute Renal InsufficiencyAnti-Glomerular Basement Membrane DiseaseAutoimmune EncephalitisAutoimmune Encephalitis (AE)Glomerulonephritis, IGAKidney DiseasesMyasthenia Gravis (MG)Myasthenic Crisis
Phase 2
Trial of Plasma Exchange for Severe Crescentic IgA Nephropathy
TerminatedNCT02647255
Start: 2016-03-31End: 2020-10-31Updated: 2021-10-08
A Trial of Caplacizumab in Japanese Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)
CompletedNCT04074187
Start: 2019-10-21End: 2021-05-19Updated: 2025-09-22
A Clinical Trial With KJ103 in Anti-GBM Disease
Active, not recruitingNCT06607016
Start: 2024-10-21End: 2026-03-31Target: 12Updated: 2025-06-13
Phase 3
Unknown Phase
CPI Combination Therapy for Autoimmune Encephalitis
CompletedNCT03542279
Start: 2020-11-25End: 2024-09-12Updated: 2025-06-27
Efficacy of IVIG Versus PLEX in Myasthenic Crisis in Syria.
CompletedNCT07532707
Start: 2022-09-01End: 2023-10-30Updated: 2026-04-16
Plasma Exchange in Children With Severe Sepsis and Septic Shock
RecruitingNCT07706413
Start: 2026-08-01End: 2027-03-31Target: 22Updated: 2026-08-24
Plasma Exchange in Pediatric Autoimmune Encephalitis
RecruitingNCT07707739
Start: 2026-08-01End: 2027-03-31Target: 22Updated: 2026-08-24